Roaring Kitty's GameStop Options up Millions, but Cashing in May Be Tricky
NEW YORK, June 4 (Reuters) - "Roaring Kitty" Keith Gill, the stock influencer behind the 2021 meme stock frenzy, may be sitting on a paper profit of tens of millions of dollars on his position in Game
Singaporeans Say Budget Fails to Ease Living Costs, Survey Finds
Majority of citizens, residents think latest aid is not enoughVouchers for groceries, food vendors credited with most impactThe spending plan announced last week is expected to swing the government bu
Crypto King Sam Bankman-Fried Convicted of Plundering Billions in Collapse of FTX
Bankman-Fried was found guilty after the collapse of his crypto exchange revealed that $8 billion in customer money had disappeared.FTX founder Sam Bankman-Fried, who just over a year ago was the king
T2 Biosystems Tumbled Another 11% on Wednesday Despite FDA Approval for Anthrax and Plague Diagnostic Test
T2 Biosystems has received FDA clearance to market and sell its T2Biothreat panel. Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test.In a statement Tuesday, T2 Biosystems announced that it has received 510 clearance from the FDA for its T2Biothreat panel. The panel is a direct-from-blood molecular diagnostic test that detects six biothreat pathogens, including the organisms that cause anthrax, plague and typhus.With the FDA clearance, T2 Biosystems can immediately start marketing and selling the T2Biothreat panel in the U.S. market.Related: T2 Biosystems reaches regulatory milestone that could be a game changer, analyst says. But T2 Biosystems' stock ended Wednesday's session down 11%. The company's shares ended Tuesday's session down 26.1% to snap a two-day winning streak that saw a 65.6% gain Monday, their biggest single-day percentage gain since Sept. 11, 2019.Related: T2 Biosy
Not crashed but minor pullback be careful with your words
T2 Biosystems Receives FDA Approval for Innovative Biothreat Detection System
T2 Biosystems recently received FDA approval for its groundbreaking T2 Biothreat Panel. This innovative multiplex nucleic acid detection system is designed to identify biothreat agents and has been de
Thanks for your concern but not interested in selling
BBBYQ Stock Alert: Get Ready for Liquidation After Sept. 12
Bed Bath & Beyond (BBBYQ) will hold a plan confirmation hearing related to its bankruptcy on Sept. 12.Shareholders should expect their interest in the company to be extinguished as part of Bed Bath’s